Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey

The [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as a cancer screening for asymptomatic subjects using FDG-PET (including PET/ computed tomography [CT]) with or without combination of other screening tests. The aim of the present study was to...

Full description

Saved in:
Bibliographic Details
Published inAnticancer research Vol. 34; no. 8; p. 4439
Main Authors Minamimoto, Ryogo, Senda, Michio, Jinnouchi, Seishi, Terauchi, Takashi, Yoshida, Tsuyoshi, Inoue, Tomio
Format Journal Article
LanguageEnglish
Published Greece 01.08.2014
Subjects
Online AccessGet full text
ISSN1791-7530
1791-7530

Cover

Abstract The [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as a cancer screening for asymptomatic subjects using FDG-PET (including PET/ computed tomography [CT]) with or without combination of other screening tests. The aim of the present study was to analyze the thyroid cancer detection rate in asymptomatic individuals through a FDG-PET cancer screening program in Japan. A total of 153,775 asymptomatic individuals underwent FDG-PET cancer screening. We analyzed 1,308 cases for possible thyroid cancer in all screening tests. Among the 1,308 possible cases, 353 were verified as thyroid cancer. The relative sensitivity and positive predictive value (PPV) of FDG-PET were 90.7% and 29.5% for thyroid cancer, respectively. The relative sensitivity was equivalent to thyroid ultrasonography (US) (90.9%) and higher than neck computed tomography (CT) (75.7%, p<0.001), thyroglobulin (36.1%, p<0.001), and carcinoembryonic antigen (5.6%, p<0.001). The sensitivity with a PET/CT scanner was higher than that with a dedicated PET scanner (94.1% vs. 85.0%, p<0.001). Combining thyroid US with FDG-PET increased the relative sensitivity and PPV. The majority of thyroid carcinomas detected by FDG-PET screening were Union for International Cancer Control (UICC) stage I, but a significant number of cases were also detected as stage III or IV. The FDG-PET cancer screening program in Japan detected thyroid cancer at an early stage. FDG-PET showed high sensitivity in detecting thyroid cancer, and it may be more effective if combined with thyroid US.
AbstractList The [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as a cancer screening for asymptomatic subjects using FDG-PET (including PET/ computed tomography [CT]) with or without combination of other screening tests. The aim of the present study was to analyze the thyroid cancer detection rate in asymptomatic individuals through a FDG-PET cancer screening program in Japan. A total of 153,775 asymptomatic individuals underwent FDG-PET cancer screening. We analyzed 1,308 cases for possible thyroid cancer in all screening tests. Among the 1,308 possible cases, 353 were verified as thyroid cancer. The relative sensitivity and positive predictive value (PPV) of FDG-PET were 90.7% and 29.5% for thyroid cancer, respectively. The relative sensitivity was equivalent to thyroid ultrasonography (US) (90.9%) and higher than neck computed tomography (CT) (75.7%, p<0.001), thyroglobulin (36.1%, p<0.001), and carcinoembryonic antigen (5.6%, p<0.001). The sensitivity with a PET/CT scanner was higher than that with a dedicated PET scanner (94.1% vs. 85.0%, p<0.001). Combining thyroid US with FDG-PET increased the relative sensitivity and PPV. The majority of thyroid carcinomas detected by FDG-PET screening were Union for International Cancer Control (UICC) stage I, but a significant number of cases were also detected as stage III or IV. The FDG-PET cancer screening program in Japan detected thyroid cancer at an early stage. FDG-PET showed high sensitivity in detecting thyroid cancer, and it may be more effective if combined with thyroid US.
The [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as a cancer screening for asymptomatic subjects using FDG-PET (including PET/ computed tomography [CT]) with or without combination of other screening tests. The aim of the present study was to analyze the thyroid cancer detection rate in asymptomatic individuals through a FDG-PET cancer screening program in Japan.BACKGROUND/AIMThe [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as a cancer screening for asymptomatic subjects using FDG-PET (including PET/ computed tomography [CT]) with or without combination of other screening tests. The aim of the present study was to analyze the thyroid cancer detection rate in asymptomatic individuals through a FDG-PET cancer screening program in Japan.A total of 153,775 asymptomatic individuals underwent FDG-PET cancer screening. We analyzed 1,308 cases for possible thyroid cancer in all screening tests.MATERIALS AND METHODSA total of 153,775 asymptomatic individuals underwent FDG-PET cancer screening. We analyzed 1,308 cases for possible thyroid cancer in all screening tests.Among the 1,308 possible cases, 353 were verified as thyroid cancer. The relative sensitivity and positive predictive value (PPV) of FDG-PET were 90.7% and 29.5% for thyroid cancer, respectively. The relative sensitivity was equivalent to thyroid ultrasonography (US) (90.9%) and higher than neck computed tomography (CT) (75.7%, p<0.001), thyroglobulin (36.1%, p<0.001), and carcinoembryonic antigen (5.6%, p<0.001). The sensitivity with a PET/CT scanner was higher than that with a dedicated PET scanner (94.1% vs. 85.0%, p<0.001). Combining thyroid US with FDG-PET increased the relative sensitivity and PPV. The majority of thyroid carcinomas detected by FDG-PET screening were Union for International Cancer Control (UICC) stage I, but a significant number of cases were also detected as stage III or IV.RESULTSAmong the 1,308 possible cases, 353 were verified as thyroid cancer. The relative sensitivity and positive predictive value (PPV) of FDG-PET were 90.7% and 29.5% for thyroid cancer, respectively. The relative sensitivity was equivalent to thyroid ultrasonography (US) (90.9%) and higher than neck computed tomography (CT) (75.7%, p<0.001), thyroglobulin (36.1%, p<0.001), and carcinoembryonic antigen (5.6%, p<0.001). The sensitivity with a PET/CT scanner was higher than that with a dedicated PET scanner (94.1% vs. 85.0%, p<0.001). Combining thyroid US with FDG-PET increased the relative sensitivity and PPV. The majority of thyroid carcinomas detected by FDG-PET screening were Union for International Cancer Control (UICC) stage I, but a significant number of cases were also detected as stage III or IV.The FDG-PET cancer screening program in Japan detected thyroid cancer at an early stage. FDG-PET showed high sensitivity in detecting thyroid cancer, and it may be more effective if combined with thyroid US.CONCLUSIONThe FDG-PET cancer screening program in Japan detected thyroid cancer at an early stage. FDG-PET showed high sensitivity in detecting thyroid cancer, and it may be more effective if combined with thyroid US.
Author Jinnouchi, Seishi
Inoue, Tomio
Yoshida, Tsuyoshi
Minamimoto, Ryogo
Senda, Michio
Terauchi, Takashi
Author_xml – sequence: 1
  givenname: Ryogo
  surname: Minamimoto
  fullname: Minamimoto, Ryogo
  email: ryogominamimoto@yahoo.co.jp
  organization: Division of Nuclear Medicine, Department of Radiology, National Center for Global Health, Tokyo, Japan Department of Radiology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan ryogominamimoto@yahoo.co.jp
– sequence: 2
  givenname: Michio
  surname: Senda
  fullname: Senda, Michio
  organization: Division of Molecular Imaging, Institute of Biomedical Research and Innovation, Kobe, Japan
– sequence: 3
  givenname: Seishi
  surname: Jinnouchi
  fullname: Jinnouchi, Seishi
  organization: Atsuchi Memorial Institute of Radiology, Atsuchi Memorial Clinic PET Center, Kagoshima, Japan
– sequence: 4
  givenname: Takashi
  surname: Terauchi
  fullname: Terauchi, Takashi
  organization: Division of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
– sequence: 5
  givenname: Tsuyoshi
  surname: Yoshida
  fullname: Yoshida, Tsuyoshi
  organization: Department of Radiology, Koga Hospital 21 PET Center, Kurume, Japan
– sequence: 6
  givenname: Tomio
  surname: Inoue
  fullname: Inoue, Tomio
  organization: Department of Radiology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25075083$$D View this record in MEDLINE/PubMed
BookMark eNpNkE1LxDAQhoOsuB_6FyRHL4WkaZLGm-yXyoIe1nNJ08la2aY1aZX-eyPugnOZYebh5WHmaOJaBxdoRqWiieSMTP7NUzQP4YMQIVTOrtA05URykrMZ0ivowfR163Brcf8--rausNHOgMfliLXDm9U2eV3vz8tgPICr3QF3vj143dxjjZ91px0EwE7_ZiXfdQU4DP4Lxmt0afUxwM2pL9DbZr1fPia7l-3T8mGXdCmlfcIti7o8F1KSUmQZWJuRCkwlgOQyoyxWqYxSlJQUlAQL1pQ8HkQaQcIW6O4vN2p9DhD6oqmDgeMxirVDKCjnhEihOI_o7QkdygaqovN1o_1YnN_CfgDUqGAf
ContentType Journal Article
Copyright Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Copyright_xml – notice: Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1791-7530
ExternalDocumentID 25075083
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
23M
53G
5GY
5RE
5VS
ADBBV
AENEX
AFFNX
AIZAD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CGR
CUY
CVF
DIK
EBS
ECM
EIF
EJD
F5P
H13
KQ8
L7B
NPM
OK1
P2P
RHI
SJN
UDS
VRB
W8F
X7M
ZGI
ZXP
7X8
ID FETCH-LOGICAL-p211t-5f3179586770b644eff40decd6e087413333b9c9910b1e97efefcb54136240d03
ISSN 1791-7530
IngestDate Fri Jul 11 11:08:55 EDT 2025
Thu Apr 03 07:09:11 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords screening
Thyroid cancer
Japan
PET
PET/CT
Language English
License Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p211t-5f3179586770b644eff40decd6e087413333b9c9910b1e97efefcb54136240d03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 25075083
PQID 1550076955
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1550076955
pubmed_primary_25075083
PublicationCentury 2000
PublicationDate 2014-Aug
20140801
PublicationDateYYYYMMDD 2014-08-01
PublicationDate_xml – month: 08
  year: 2014
  text: 2014-Aug
PublicationDecade 2010
PublicationPlace Greece
PublicationPlace_xml – name: Greece
PublicationTitle Anticancer research
PublicationTitleAlternate Anticancer Res
PublicationYear 2014
SSID ssj0066983
Score 2.0979908
Snippet The [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as a cancer screening for asymptomatic subjects using...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 4439
SubjectTerms Adult
Early Detection of Cancer
Female
Fluorodeoxyglucose F18
Humans
Japan
Male
Middle Aged
Neoplasm Staging
Positron-Emission Tomography - methods
Radiopharmaceuticals
Thyroid Neoplasms - diagnostic imaging
Thyroid Neoplasms - pathology
Tomography, X-Ray Computed
Title Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey
URI https://www.ncbi.nlm.nih.gov/pubmed/25075083
https://www.proquest.com/docview/1550076955
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1791-7530
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0066983
  issn: 1791-7530
  databaseCode: KQ8
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1791-7530
  dateEnd: 20231002
  omitProxy: true
  ssIdentifier: ssj0066983
  issn: 1791-7530
  databaseCode: DIK
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEBZNHkpfSu-mFyqUvgQVbyL5yFtodptus2kpXtg3Y0mjYAr2duNtSH59RtaRBFJIuw9mGeEDffbom9EchHzANSnnPNHM7CjJuNCC1bk2zGhuCoW6kg-5MLPj9HDOpwuxuGp3NGSX9PKTurg1r-R_UEUZ4mqzZP8B2XhRFOB_xBePiDAe74TxAfSgAuXDGV91jbZhXApWllbipzs5-MJ-jMsgRB2BdqtLQB_islyu8xRXTNuJctu5BtlZo2H7dL36c3PTd7-1ju_hQr5GUPQlzxrb2B5hHzyvP8-7ky76bgCt_hCh30TxtGnbznZiGfyvYF1h0Ytgi4H6kbL-VYch75wY8RgaF_RpVowYWkRu6wVukXkl7D2a7mXLr2lUzl2xo5ulso-_V5P50VFVjhflx-VvZruI2d1231Jlg2ygHrMU-eu3sC6naTEUZY23_7tNMXCL8hF56I0Cuu8QfkzuQfuE3J_5sIenpI5A085QDzR1UFB5TuuWeqCDMAJNPdB7tKYBZnoNZupgfkbmk3H5-ZD53hhsiSZ7z4RB4lcIW40wkchpwRj84kDpFJIcWeIu_mShkP0ncgRFBgaMkgIHUuRwOtl9TjbbroWXhILkCnnjzkgjeU6MkIbbKpAilwWozCRb5H2Ypwp1j91Qwoft1qeVNW-TLC2E2CIv3ARWS1ckpUJqndlWA6_ucPZr8uDq5XlDNvvVGt4i1-vluwHCS7jjXBs
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Detection+of+thyroid+cancer+by+an+FDG-PET+cancer+screening+program%3A+a+Japanese+nation-wide+survey&rft.jtitle=Anticancer+research&rft.au=Minamimoto%2C+Ryogo&rft.au=Senda%2C+Michio&rft.au=Jinnouchi%2C+Seishi&rft.au=Terauchi%2C+Takashi&rft.date=2014-08-01&rft.issn=1791-7530&rft.eissn=1791-7530&rft.volume=34&rft.issue=8&rft.spage=4439&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1791-7530&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1791-7530&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1791-7530&client=summon